Cited by 354Characterization and Applications of Magnetic NanoparticlesNanoparticle-Based Drug DeliveryUltrasound and Hyperthermia Applications

Cancer hyperthermia using magnetic nanoparticles

Kobayashi, Takeshi·2011·Biotechnology Journal

Abstract

Magnetic‐nanoparticle‐mediated intracellular hyperthermia has the potential to achieve localized tumor heating without any side effects. The technique consists of targeting magnetic nanoparticles to tumor tissue followed by application of an external alternating magnetic field that induces heat through Néel relaxation loss of the magnetic nanoparticles. The temperature in tumor tissue is increased to above 43°C, which causes necrosis of cancer cells, but does not damage surrounding normal tissue. Among magnetic nanoparticles available, magnetite has been extensively studied. Recent years have seen remarkable advances in magnetite‐nanoparticle‐mediated hyperthermia; both functional magnetite nanoparticles and alternating‐magnetic‐field generators have been developed. In addition to the expected tumor cell death, hyperthermia treatment has also induced unexpected biological responses, such as tumor‐specific immune responses as a result of heat‐shock protein expression. These results suggest that hyperthermia is able to kill not only local tumors exposed to heat treatment, but also tumors at distant sites, including metastatic cancer cells. Currently, several research centers have begun clinical trials with promising results, suggesting that the time may have come for clinical applications. This review describes recent advances in magnetite nanoparticle‐mediated hyperthermia.

Integrity signals

Registry

Crossref · 10.1002/biot.201100045

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The magnetic response intelligent nano system has two treatment procedures: the first uses magnetic fields to assist drug targeting, and the second uses magnetic fields to cause hyperthermia.

    “As a result, the magnetic response intelligent nano system has two treatment procedures. The first technique uses magnetic fields to assist drug targeting, whereas the second uses magnetic fields to cause hyperthermia.186–188”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [186]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kobayashi, T.
Affiliations
Chubu University (JP)
Corresponding author
Kobayashi, Takeshi
Venue
Biotechnology Journal
Publisher
Wiley
Published
2011-08-26
Volume
6
Issue
11
Pages
1342-1347
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W2025547067
Cited by
354
References
18
Citations by year
2026: 13 · 2025: 21 · 2024: 27 · 2023: 26 · 2022: 22 · 2021: 28 · 2020: 29 · 2019: 26 · 2018: 32 · 2017: 17 · 2016: 34 · 2015: 23 · 2014: 22 · 2013: 23 · 2012: 9
FWCI
10.40
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (21550165)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
Keywords
cancer hyperthermia, magnetic nanoparticles, Fe3O4 nanoparticles, Néel relaxation, alternating magnetic field, tumor heating, tumor necrosis, tumor-specific immunity, heat shock proteins, metastatic cancer, clinical trials
MeSH terms
Animals, Clinical Trials as Topic, Hot Temperature, Heat-Shock Proteins, Humans, Hyperthermia, Induced, Magnetics, Neoplasms, Anticarcinogenic Agents, Models, Animal, Cell Line, Tumor, Magnetite Nanoparticles, Magnetic Fields

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review